ARWR
NASDAQ · Biotechnology
Arrowhead Pharmaceuticals In
$71.86
+3.07 (+4.46%)
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Q3 FY2026 | $-1.35 | — | — | — | — |
| May 7, 2026 | Q2 FY2026 | $-1.21 | — | — | — | — |